<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Rheumatic fever</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Rheumatic fever.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/rheumatic-fever.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Rheumatic fever/rheumatic heart disease, contemporary concepts, emerging paradigms and Indian perspective</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-4103-ijoc-ijoc-14-26-798038bf/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-4103-ijoc-ijoc-14-26-798038bf/</guid>
    <pubDate>Sat, 08 Aug 2026 00:00:00 GMT</pubDate>
    <description>Strengthening regional health infrastructure through coordinated diagnostic expansion and reliable medication supply chains is highlighted as essential for reducing ongoing morbidity.</description>
    <category>Rheumatic fever</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>&lt;i&gt;Streptococcus Pyogenes&lt;/i&gt; and Acute Rheumatic Fever: How Strong are the Links in the Chain?</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-5334-gh-1564-608dcc05/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-5334-gh-1564-608dcc05/</guid>
    <pubDate>Fri, 19 Jun 2026 00:00:00 GMT</pubDate>
    <description>The synthesized information supports ongoing discussions regarding prophylactic interventions and regulatory approvals for novel immunizations. Policy formulation benefits from understanding where current knowledge remains incomplete.</description>
    <category>Rheumatic fever</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>CXCR3 is associated with T-cell-induced heart damage in acute rheumatic fever.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-71094-8-c913ca6c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-71094-8-c913ca6c/</guid>
    <pubDate>Tue, 31 Mar 2026 00:00:00 GMT</pubDate>
    <description>The findings identify a perturbed T cell compartment in acute rheumatic fever and provide a mechanistic rationale for exploring currently available immune-modulating therapies to treat the disease and prevent progressive cardiac damage.</description>
    <category>Rheumatic fever</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Acute Rheumatic Fever Diagnostic Network (ARC Network) clinical recruitment protocol.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmjopen-2025-114968-88ac78c2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmjopen-2025-114968-88ac78c2/</guid>
    <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
    <description>The project addresses a critical testing gap in regions experiencing substantial disease burden by constructing a platform for future diagnostic development.</description>
    <category>Rheumatic fever</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Acute rheumatic fever and rheumatic heart disease.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41572-026-00685-y-414150e9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41572-026-00685-y-414150e9/</guid>
    <pubDate>Thu, 26 Feb 2026 00:00:00 GMT</pubDate>
    <description>The condition represents a significant source of preventable cardiovascular morbidity and mortality worldwide, underscoring the necessity for sustained institutional funding and strategic policy alignment to reach global elimination objectives.</description>
    <category>Rheumatic fever</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Rheumatic heart disease in the setting of lupus anticoagulant antibodies without history of rheumatic fever</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1007-s44162-026-00154-w-8b6a74da/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1007-s44162-026-00154-w-8b6a74da/</guid>
    <pubDate>Mon, 02 Feb 2026 00:00:00 GMT</pubDate>
    <description>The case suggests a potential immunologic link between lupus anticoagulant antibodies and rheumatic-type cardiac valve pathology through cross-reactivity with anti-m protein pathways, though this remains mechanistically speculative.</description>
    <category>Rheumatic fever</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Resurgence of rheumatic fever among Pacific peoples in Aotearoa New Zealand: A 2010–2023 analysis of hospitalisation data with implications for equity policy</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-anzjph-2025-100301-d7828ffc/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-anzjph-2025-100301-d7828ffc/</guid>
    <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
    <description>Addressing persistent disparities requires improved monitoring infrastructure and targeted resource allocation to achieve established national health objectives.</description>
    <category>Rheumatic fever</category>
    <category>COVID-19</category>
    <category>Surveillance</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>“It Can Hurt Your Heart”: A Co-Designed Cross-Sectional Survey Exploring Pacific People’s Understanding of Rheumatic Fever in Auckland, New Zealand</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-healthcare13222924-8e4c34ca/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-healthcare13222924-8e4c34ca/</guid>
    <pubDate>Sat, 15 Nov 2025 00:00:00 GMT</pubDate>
    <description>Documented knowledge deficiencies suggest that localized educational programs could strengthen preventive practices and encourage earlier clinical consultation. Integrating digital communication strategies may effectively extend the reach of these public health messages.</description>
    <category>Rheumatic fever</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Circulating prothymosin alpha and immunoglobulin G3 in acute rheumatic fever and rheumatic heart disease: A case-control study.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ahjo-2025-100630-7f7211ab/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ahjo-2025-100630-7f7211ab/</guid>
    <pubDate>Mon, 29 Sep 2025 00:00:00 GMT</pubDate>
    <description>Findings are relevant to the lack of specific diagnostic tests for acute rheumatic fever and rheumatic heart disease in low-resource settings, where these diseases impose the greatest burden.</description>
    <category>Rheumatic fever</category>
    <category>Diagnostics</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Diverse diagnostic and management approaches for acute rheumatic fever in Australia and New Zealand: findings of a prospective clinical study.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmjopen-2025-099827-90b6b044/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmjopen-2025-099827-90b6b044/</guid>
    <pubDate>Thu, 17 Jul 2025 00:00:00 GMT</pubDate>
    <description>Documented discrepancies in clinical workflows and patient outcomes underscore the necessity for harmonized regional guidelines tailored to specific epidemiological contexts.</description>
    <category>Rheumatic fever</category>
    <category>Diagnostics</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Exploring How Rheumatic Fever Is Portrayed on TikTok: A Descriptive Content Analysis.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-ijerph22050686-8476387e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-ijerph22050686-8476387e/</guid>
    <pubDate>Sat, 26 Apr 2025 00:00:00 GMT</pubDate>
    <description>The findings point to opportunities for future health promotion on TikTok to address identified content gaps, including where to seek health services, primordial prevention, and narratives of recovery, given the platform&apos;s broad reach and primarily negative framing of rheumatic fever content.</description>
    <category>Rheumatic fever</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Acute rheumatic fever in Canterbury, Aotearoa New Zealand, 2012–2022</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-26635-6965-6593-640b2fba/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-26635-6965-6593-640b2fba/</guid>
    <pubDate>Fri, 14 Feb 2025 00:00:00 GMT</pubDate>
    <description>Monitoring this patient group requires coordinated cross-jurisdictional tracking since most individuals undergoing continuous preventive therapy relocated to the area from northern or Pacific territories.</description>
    <category>Rheumatic fever</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
